EP2663306A4 - Polymorphe aus dexlansoprazolsalzen - Google Patents
Polymorphe aus dexlansoprazolsalzenInfo
- Publication number
- EP2663306A4 EP2663306A4 EP11855797.4A EP11855797A EP2663306A4 EP 2663306 A4 EP2663306 A4 EP 2663306A4 EP 11855797 A EP11855797 A EP 11855797A EP 2663306 A4 EP2663306 A4 EP 2663306A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- dexlansoprazole
- polymorphs
- salts
- dexlansoprazole salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN102CH2011 | 2011-01-12 | ||
PCT/IN2011/000782 WO2012095859A1 (en) | 2011-01-12 | 2011-11-11 | Polymorphs of dexlansoprazole salts |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2663306A1 EP2663306A1 (de) | 2013-11-20 |
EP2663306A4 true EP2663306A4 (de) | 2014-01-01 |
Family
ID=46506821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11855797.4A Withdrawn EP2663306A4 (de) | 2011-01-12 | 2011-11-11 | Polymorphe aus dexlansoprazolsalzen |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2663306A4 (de) |
WO (1) | WO2012095859A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103788068B (zh) * | 2014-02-26 | 2016-04-06 | 南京海融医药科技有限公司 | 高熔点的手性苯并咪唑类化合物钠盐、制备方法及其用途 |
CN106727381B (zh) * | 2016-12-29 | 2020-07-07 | 南京海融制药有限公司 | 一种右兰索拉唑钠的口崩片及其制备方法 |
CN106668018B (zh) * | 2016-12-29 | 2019-12-06 | 南京海融制药有限公司 | 一种右兰索拉唑钠的缓释胶囊及其制备方法 |
CN106749186B (zh) * | 2016-12-29 | 2019-03-05 | 南京海融制药有限公司 | 一种右兰索拉唑钠的新晶型及其制备方法 |
CN106619520B (zh) * | 2016-12-29 | 2019-08-06 | 南京海融制药有限公司 | 一种右兰索拉唑钠的干混悬剂及其制备方法 |
CN109836413A (zh) * | 2017-11-27 | 2019-06-04 | 银谷制药有限责任公司 | 一种右旋兰索拉唑钠晶型及其制备方法和用途 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000078729A1 (en) * | 1999-06-18 | 2000-12-28 | Instytut Farmaceutyczny | Crystalline forms of lansoprazole |
WO2003082857A2 (en) * | 2002-03-27 | 2003-10-09 | Teva Pharmaceutical Industries Ltd. | Lansoprazole polymorphs and processes for preparation thereof |
WO2004083200A1 (en) * | 1999-06-17 | 2004-09-30 | Akira Fujishima | Crystalline form of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
EP1889841A1 (de) * | 2005-06-07 | 2008-02-20 | Takeda Pharmaceutical Company Limited | Kristall eines salzes einer benzimidazolverbindung |
WO2009087672A1 (en) * | 2007-12-18 | 2009-07-16 | Watson Pharma Private Limited | A process for preparation of stable amorphous r-lansoprazole |
WO2010039885A2 (en) * | 2008-09-30 | 2010-04-08 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of dexlansoprazole |
WO2010056059A2 (en) * | 2008-11-14 | 2010-05-20 | Hanmi Pharm. Co., Ltd. | Novel crystalline dexlansoprazole and pharmaceutical composition comprising same |
EP2216333A2 (de) * | 2009-02-06 | 2010-08-11 | Dipharma Francis S.r.l. | Kristalline Formen von Dexlansoprazol |
WO2011121546A1 (en) * | 2010-03-31 | 2011-10-06 | Ranbaxy Laboratories Limited | Salts of dexlansoprazole and their preparation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4104470A (en) * | 1977-06-03 | 1978-08-01 | Eli Lilly And Company | Crystallization process for cefazolin sodium |
EP1306375B1 (de) * | 2000-08-04 | 2006-10-11 | Takeda Pharmaceutical Company Limited | Salze von benzimidazol-derivaten und deren verwendung |
CA2510849A1 (en) * | 2002-12-19 | 2004-07-08 | Teva Pharmaceutical Industries Ltd | Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
WO2006069159A2 (en) * | 2004-12-20 | 2006-06-29 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions comprising amorphous benzimidazole compounds |
WO2007122686A1 (ja) * | 2006-04-14 | 2007-11-01 | Eisai R & D Management Co., Ltd. | ベンズイミダゾール化合物 |
US20110028518A1 (en) * | 2008-03-18 | 2011-02-03 | Dr. Reddy's Laboratories Ltd. | Dexlansoprazole process and polymorphs |
-
2011
- 2011-11-11 EP EP11855797.4A patent/EP2663306A4/de not_active Withdrawn
- 2011-11-11 WO PCT/IN2011/000782 patent/WO2012095859A1/en active Application Filing
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004083200A1 (en) * | 1999-06-17 | 2004-09-30 | Akira Fujishima | Crystalline form of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
WO2000078729A1 (en) * | 1999-06-18 | 2000-12-28 | Instytut Farmaceutyczny | Crystalline forms of lansoprazole |
WO2003082857A2 (en) * | 2002-03-27 | 2003-10-09 | Teva Pharmaceutical Industries Ltd. | Lansoprazole polymorphs and processes for preparation thereof |
EP1889841A1 (de) * | 2005-06-07 | 2008-02-20 | Takeda Pharmaceutical Company Limited | Kristall eines salzes einer benzimidazolverbindung |
WO2009087672A1 (en) * | 2007-12-18 | 2009-07-16 | Watson Pharma Private Limited | A process for preparation of stable amorphous r-lansoprazole |
WO2010039885A2 (en) * | 2008-09-30 | 2010-04-08 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of dexlansoprazole |
WO2010056059A2 (en) * | 2008-11-14 | 2010-05-20 | Hanmi Pharm. Co., Ltd. | Novel crystalline dexlansoprazole and pharmaceutical composition comprising same |
EP2216333A2 (de) * | 2009-02-06 | 2010-08-11 | Dipharma Francis S.r.l. | Kristalline Formen von Dexlansoprazol |
WO2011121546A1 (en) * | 2010-03-31 | 2011-10-06 | Ranbaxy Laboratories Limited | Salts of dexlansoprazole and their preparation |
Non-Patent Citations (1)
Title |
---|
See also references of WO2012095859A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2663306A1 (de) | 2013-11-20 |
WO2012095859A1 (en) | 2012-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6960542A2 (es) | Polimorfos de inhibidores de cinasas | |
IL232599A (en) | Hydrobromide salt of peridofidine | |
SI2707368T1 (sl) | Polimorf linagliptin benzoata | |
EP2709609A4 (de) | Heterozyklische verbindungen | |
IL230976A (en) | Crystalline forms of Czebitaxel | |
HK1195770A1 (en) | Amorphous solid salts of cobicistat (gs-9350) (cobicistat)(gs-9350) | |
HK1201271A1 (en) | Kinase inhibitor polymorphs | |
GB201304499D0 (en) | Carcainium Salts | |
EP2776393A4 (de) | Nampt-inhibitoren | |
EP2760853A4 (de) | Neuartige salze aus alogliptin | |
SG11201400452TA (en) | Derivatives of xanthone compounds | |
EP2800747A4 (de) | Polymorphe von perampanel | |
EP2758387A4 (de) | Pyridinverbindungen als kinase-inhibitoren | |
PL3287131T3 (pl) | Terapeutyczne zastosowania ektoiny | |
ZA201308160B (en) | Crystalline salts of asenapine | |
GB201120644D0 (en) | Herbicidal uses of compounds | |
HK1203355A1 (en) | Uses of 4-desferrithiocin analogs 4- | |
EP2663306A4 (de) | Polymorphe aus dexlansoprazolsalzen | |
PT2751081T (pt) | Forma polimórfica de pitavastatina cálcica | |
EP2785766A4 (de) | Hydroxypolyaminsalze | |
EP2694705A4 (de) | Mikrofabrikation von tunneln | |
EP2688649A4 (de) | Polymorphe von lenalidomid | |
EP2680843A4 (de) | Derivate von pyrazolsubstituierten amino-heteroaryl-verbindungen | |
EP2684869A4 (de) | Herstellung von 3-mercaptopropionaten | |
IL230977A (en) | A crystalline form of relapaldib |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130724 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20131129 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/4439 20060101ALI20131125BHEP Ipc: C07D 401/12 20060101AFI20131125BHEP |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140603 |